Work

Long lasting complete regression of a metastatic polyomavirus-positive Merkel cell carcinoma after COVID-19 booster vaccination

Year: 2024

Type: article

Abstract: Merkel cell carcinoma (MCC) is a rare but highly aggressive primary cutaneous neuroendocrine cancer whose incidence is increasing worldwide. MCC represents the second leading cause of skin cancer death after melanoma [1,2]. It typically manifests as a red nodule or plaque with fast growth, most commonly on sun exposed areas [3]. Risk factors include fair skin type, advanced age, ultraviolet radiation exposure, male sex, immunosuppression, and integration of Merkel cell polyomavirus DNA (MCPyV) into the host genome [3].

Source: EJC Skin Cancer

DOI: 10.1016/j.ejcskn.2024.100275

Authors: Ulrich Wesselmann, Hans M. Kvasnicka, Ahmet Bozkurt, Ulrike Wieland, Silke C. Hofmann

Institutions: Witten/Herdecke University, Helios Universitätsklinikum Wuppertal, University of Cologne, University Hospital Cologne

Language: English

Topic: Polyomavirus and related diseases

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,200